强效的、口服活性的基于咪唑并[4,5-b]吡啶的血管紧张素II受体拮抗剂。 - Suppr

Suppr

超能文献

Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists.

作者信息

Mantlo N B, Chakravarty P K, Ondeyka D L, Siegl P K, Chang R S, Lotti V J, Faust K A, Chen T B, Schorn T W, Sweet C S

机构信息

Exploratory Chemistry Merck Sharp and Dohme Research Laboratories, Rahway, New Jersey 07065.

出版信息

J Med Chem. 1991 Sep;34(9):2919-22. doi: 10.1021/jm00113a035.

DOI:10.1021/jm00113a035

PMID:1895308

Abstract

摘要

相似文献

Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists.强效的、口服活性的基于咪唑并[4,5-b]吡啶的血管紧张素II受体拮抗剂。

J Med Chem. 1991 Sep;34(9):2919-22. doi: 10.1021/jm00113a035.

A highly potent, orally active imidazo[4,5-b]pyridine biphenylacylsulfonamide (MK-996; L-159,282): a new AT1-selective angiotensin II receptor antagonist.一种高效、口服活性的咪唑并[4,5-b]吡啶联苯酰磺酰胺（MK-996；L-159,282）：一种新型的AT1选择性血管紧张素II受体拮抗剂。

J Med Chem. 1994 Nov 25;37(24):4068-72. doi: 10.1021/jm00050a002.

In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.新型高效选择性非肽类血管紧张素II受体拮抗剂L-158,809的体内药理学

J Pharmacol Exp Ther. 1992 Jul;262(1):139-44.

In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.新型非肽类血管紧张素II受体拮抗剂UP 269-6的体内药理学特性

Eur J Pharmacol. 1995 Sep 15;284(1-2):157-70. doi: 10.1016/0014-2999(95)00395-2.

Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.非肽类血管紧张素II受体拮抗剂。XI. EXP3174的药理学：一种口服活性抗高血压药物DuP 753的活性代谢产物。

J Pharmacol Exp Ther. 1990 Oct;255(1):211-7.

Synthesis and evaluation of novel nonpeptide angiotensin II receptor antagonists: imidazo[4,5-c]pyridine derivatives with an aromatic substituent.

Chem Pharm Bull (Tokyo). 1995 Mar;43(3):450-60. doi: 10.1248/cpb.43.450.

In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996.新型AT1选择性血管紧张素II受体拮抗剂MK-996的体内药理学

Am J Hypertens. 1995 Jan;8(1):58-66. doi: 10.1016/0895-7061(94)00169-c.

[Nonpeptide angiotensin II receptor antagonists].[非肽类血管紧张素 II 受体拮抗剂]

Tanpakushitsu Kakusan Koso. 1993 Aug;38(11):1873-80.

Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.

J Med Chem. 1991 Aug;34(8):2525-47. doi: 10.1021/jm00112a031.

[Nonpeptide angiotensin II antagonists].[非肽类血管紧张素 II 拮抗剂]

Nihon Rinsho. 1992 Apr;50 Suppl:753-63.

引用本文的文献

Rational Design and Synthesis of AT1R Antagonists.血管紧张素受体拮抗剂的合理设计与合成。

Molecules. 2021 May 14;26(10):2927. doi: 10.3390/molecules26102927.

Tautomerization, molecular structure, transition state structure, and vibrational spectra of 2-aminopyridines: a combined computational and experimental study.2-氨基吡啶的互变异构、分子结构、过渡态结构及振动光谱：计算与实验相结合的研究

Springerplus. 2015 Oct 9;4:586. doi: 10.1186/s40064-015-1363-2. eCollection 2015.

Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.缬沙坦的药理学特性：一种强效、口服活性的血管紧张素II AT1受体亚型非肽拮抗剂。

Br J Pharmacol. 1993 Oct;110(2):761-71. doi: 10.1111/j.1476-5381.1993.tb13877.x.

A 3D QSAR approach to the search for geometrical similarity in a series of nonpeptide angiotensin II receptor antagonists.一种用于在一系列非肽类血管紧张素 II 受体拮抗剂中寻找几何相似性的三维定量构效关系方法。

J Comput Aided Mol Des. 1994 Apr;8(2):211-20. doi: 10.1007/BF00119868.

Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.参与培养的血管平滑肌细胞DNA合成的血管紧张素II AT1受体亚型的特性研究

Br J Pharmacol. 1994 Aug;112(4):1195-201. doi: 10.1111/j.1476-5381.1994.tb13210.x.

Derivation of a 3D pharmacophore model for the angiotensin-II site one receptor.血管紧张素II 1型受体的三维药效团模型的推导

J Comput Aided Mol Des. 1994 Oct;8(5):491-512. doi: 10.1007/BF00123662.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验